ArticleFrontiers in medicine2026
Multimodal data integration and machine learning methods for early detection and risk prediction of pulmonary diseases in athletes.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pulmonary diseases pose significant health risks to athletes, necessitating accurate early detection and risk prediction methods. In this study, we propose a novel Multimodal Pulmonary Risk Prediction Network (MPRPN), which integrates visual data, textual data, and auxiliary physiological data through a unified deep learning framework. Methods: The model incorporates an Adaptive Modality Weighting Strategy (AMWS) to dynamically adjust modality contributions and a Hierarchical Risk Prediction Strategy (HRPS) to capture domain-specific feature structures. Experiments were conducted on multiple multimodal datasets, including the Athlete Respiratory Health Records dataset, Multimodal Pulmonary Imaging Collection, Pulmonary Risk Profiles dataset, and Early Detection Biomarker dataset, comprising diverse clinical, imaging, and physiological samples. Results and discussion: The proposed method achieves superior performance compared to state-of-the-art models, with accuracy improvements up to 89.92%, F1-score reaching 90.23%, and AUC up to 90.47%, demonstrating strong predictive capability and robustness. These results indicate that MPRPN effectively leverages complementary multimodal information and provides a reliable tool for early detection and personalized risk assessment of pulmonary diseases in athletes. The proposed framework has significant potential for real-world applications in sports medicine and preventive healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.